Ocular Therapeutix [OCUL] vs Immunocore Holdings [IMCR] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 11 vital metrics comparison: Ocular Therapeutix wins in 3 metrics, Immunocore Holdings wins in 7 metrics, with 0 ties. Immunocore Holdings appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricOcular TherapeutixImmunocore HoldingsBetter
P/E Ratio (TTM)N/A-31.41N/A
Price-to-Book Ratio4.874.13Immunocore Holdings
Debt-to-Equity Ratio28.66114.67Ocular Therapeutix
PEG Ratio-7.97-18.20Immunocore Holdings
EV/EBITDA-5.06-45.52Immunocore Holdings
Profit Margin91.17%-6.48%Ocular Therapeutix
Operating Margin-597.47%-3.85%Immunocore Holdings
Return on Equity-57.19%-5.86%Immunocore Holdings
Return on Assets-27.21%-1.83%Immunocore Holdings
Free Cash Flow$-135.97M$20.89MImmunocore Holdings
1-Year Return18.20%-17.97%Ocular Therapeutix
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Ocular Therapeutix vs Immunocore Holdings Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Ocular Therapeutix vs Immunocore Holdings Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...